Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Update

Arcadia Biosciences, Inc. (NASDAQ:RKDAGet Free Report) was the recipient of a large increase in short interest in the month of February. As of February 13th, there was short interest totaling 15,855 shares, an increase of 45.4% from the January 29th total of 10,905 shares. Approximately 1.0% of the company’s stock are sold short. Based on an average daily trading volume, of 14,132 shares, the days-to-cover ratio is presently 1.1 days. Based on an average daily trading volume, of 14,132 shares, the days-to-cover ratio is presently 1.1 days. Approximately 1.0% of the company’s stock are sold short.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d-)” rating on shares of Arcadia Biosciences in a report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

Read Our Latest Report on RKDA

Arcadia Biosciences Stock Up 0.4%

Shares of NASDAQ:RKDA traded up $0.01 on Monday, reaching $1.96. The company had a trading volume of 13,861 shares, compared to its average volume of 14,565. Arcadia Biosciences has a twelve month low of $1.54 and a twelve month high of $6.71. The stock has a 50-day moving average price of $2.14 and a 200 day moving average price of $3.19. The stock has a market capitalization of $3.39 million, a P/E ratio of 0.77 and a beta of 0.57.

Arcadia Biosciences Company Profile

(Get Free Report)

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.

Recommended Stories

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.